HomeCompareBMXXY vs EPRT

BMXXY vs EPRT: Dividend Comparison 2026

BMXXY yields 0.79% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMXXY wins by $2.10M in total portfolio value· pulled ahead in Year 5
10 years
BMXXY
BMXXY
● Live price
0.79%
Share price
$12.44
Annual div
$0.10
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.16M
Annual income
$1,739,853.91
Full BMXXY calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — BMXXY vs EPRT

📍 BMXXY pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMXXYEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMXXY + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BMXXY pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMXXY
Annual income on $10K today (after 15% tax)
$67.12/yr
After 10yr DRIP, annual income (after tax)
$1,478,875.82/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, BMXXY beats the other by $1,467,680.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMXXY + EPRT for your $10,000?

BMXXY: 50%EPRT: 50%
100% EPRT50/50100% BMXXY
Portfolio after 10yr
$1.11M
Annual income
$876,512.38/yr
Blended yield
78.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

BMXXY
No analyst data
Altman Z
7.5
Piotroski
7/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMXXY buys
0
EPRT buys
0
No recent congressional trades found for BMXXY or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMXXYEPRT
Forward yield0.79%3.97%
Annual dividend / share$0.10$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%29%
Portfolio after 10y$2.16M$64.3K
Annual income after 10y$1,739,853.91$13,170.85
Total dividends collected$2.11M$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BMXXY vs EPRT ($10,000, DRIP)

YearBMXXY PortfolioBMXXY Income/yrEPRT PortfolioEPRT Income/yrGap
1$10,858$157.93$11,212$512.01$354.00EPRT
2$11,938$320.51$12,689$692.09$751.00EPRT
3$13,433$658.71$14,521$944.30$1.1KEPRT
4$15,759$1,385.36$16,841$1,302.88$1.1KEPRT
5← crossover$19,899$3,037.77$19,841$1,821.64+$58.00BMXXY
6$28,462$7,170.10$23,818$2,587.47+$4.6KBMXXY
7$49,624$19,169.19$29,230$3,744.65+$20.4KBMXXY
8$115,567$62,469.69$36,816$5,540.38+$78.8KBMXXY
9$395,588$271,931.01$47,806$8,413.17+$347.8KBMXXY
10$2,163,133$1,739,853.91$64,324$13,170.85+$2.10MBMXXY

BMXXY vs EPRT: Complete Analysis 2026

BMXXYStock

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Full BMXXY Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this BMXXY vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMXXY vs SCHDBMXXY vs JEPIBMXXY vs OBMXXY vs KOBMXXY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.